Stay updated on Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial
Sign up to get notified when there's something new on the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page.

Latest updates to the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedAdded Revision: v3.4.2 and removal of the general government funding/operating status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check20 days agoChange DetectedA government funding lapse notice banner was added. The site version was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedThe page updated with a new 'Show glossary' option, capitalization adjustments for QC labels ('Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'), and a revision bump to v3.4.0.SummaryDifference0.2%

- Check42 days agoChange DetectedThe site revision label in the footer was updated from Revision: v3.3.3 to Revision: v3.3.4.SummaryDifference0.1%

- Check63 days agoChange DetectedFooter updates: added Revision: v3.3.3 and removed HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.1%

- Check92 days agoChange DetectedThe Publications section adds a note that publications are provided voluntarily by the person entering information about the study and pertain to the study results, and the revision label is updated to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Prevnar 13/Pneumovax 23 Safety/Immunogenicity in Adults 50+ Clinical Trial page.